1st

2nd INTERNATIONAL MADRID MEN´S HEALTH MEETING

Wednesday October 5th, 2016

12 de Octubre University Hospital.Madrid, Spain.

PROGRAMA DEFINITIVO

2 nd INTERNATIONAL MADRIDMEN´S HEALTH MEETING

www.madridmenshealthmeeting.com

1st

DATE: Wednesday October 5th, 2016

VENUE: 12 de Octubre University Hospital. Avda. de Córdoba s/n. 28041 - Madrid.

REGISTRATION FEE: €300 (+21% VAT)

The registration fee includes: Documentation, participation in scienti�c events, lunch and co�ees.

ORGANIZERS:

MAIN SPONSORS:

Operandro

SPD

-PTR

-5-1

6/IN

V

Gran Vía, 81 - 5º Dpto. 5 - 48011 Bilbao

Tel.: (0034) 94 427 88 55 | E-mail: info@congresosxxi.com

Simultaneous interpreting Spanish-English-Spanish will be available.

SUPPORTED BY:

Hospital Universitario12 de Octubre

TechnicalSecretariat:

COLLABORATORS:

Dr. Alberto Bossi. Gustave Roussy Cancer Institute in Villejuif, France.Dr. Giorgio Bozzini. Mater Domini Humanitas. Castellanza, Italy.Prof. Joaquín Carballido Rodríguez. Head Department of Urology, Puerta de Hierro-Majadahonda University Hospital. Madrid, Spain.

Dr. Daniel Castellano Gauna. 12 de Octubre University Hospital. Madrid, Spain.

Prof. Xavier Cathelineau. Institut Mutualiste Montsouris. Paris, France.

Dr. Natalio Cruz Navarro. ANDROMEDI Clinic. Andrology and Sexual Medicine. Sevilla, Spain.

Dr. Rados P. Djinovic. “Sava Perovic Foundation” Center for Genito-Urinary Reconstructive Surgery. Belgrade. ESGURS (EAU Section for Genito-Urinary Reconstructive Surgery)

Dr. Mario Domínguez Esteban. Marqués de Valdecilla University Hospital. Santander, Spain.

Dr. José Manuel Duarte Ojeda. Department of Urology, Prostatic Pathology Unit. 12 de Octubre University Hospital. Madrid, Spain.

Dr. James Eastham. Memorial Sloan Kettering Cancer Center. New York.

Dr. Agustín Fraile Poblador. Ramón y Cajal Universitary Hospital, Madrid.

Dr. Giulio Garaffa. St Peter's Andrology and the Institute of Urology, University College London Hospitals. London, England.

Dr. Borja García Gómez. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Lucía García González. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Carlos Hernández Fernández. Head Department of Urology, Gregorio

Marañón General University Hospital. Madrid, Spain.

Dr. Enrique Lledó García. Gregorio Marañón General University Hospital. Madrid, Spain.

Dr. Carlos Llorente. Hospital Universitario Fundación Alcorcón. Madrid, Spain.

Dr. Luis Martínez Piñeiro. Infanta Sofía University Hospital, Madrid, Spain.

Dr. Alejandro Martín Parada. Salamanca University Hospital. Salamanca, Spain.

Dr. Juan Ignacio Martínez-Salamanca. Puerta de Hierro-Majadahonda University Hospital. Madrid, Spain.

Dr. Seva Matveev. Head Department of Urology, N.N. Blokhin Cancer Research Center, Moscow. Professor of oncology, Lomonosov Moscow State University.

Dr. José Medina Polo. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Caroline Moore. University College London Hospital Trust. London, England.

Dr. Alfredo Rodríguez Antolín. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Javier Romero-Otero. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Eduard Ruiz Castañé. Puigvert Foundation, Barcelona, Spain.

Dr. Rafael Sánchez Salas. Institute Mutualiste Montsouris, Paris, France.

Dr. Joaquim Sarquella Geli. Puigvert Foundation, Barcelona, Spain.

Dr. Josep Torremadé Barreda. Bellvitge University Hospital, Barcelona, Spain.

Dr. Karim Touijer. Memorial Sloan Kettering Cancer Center. New York.

PARTICIPANTS

DIRECTORS:Dr. Javier Romero-Otero / Dr. Karim Touijer / Dr. Alfredo Rodríguez Antolín

DIRECTORS: Dr. Javier Romero-Otero / Dr. Karim Touijer / Dr. Alfredo Rodríguez Antolín

08:00 Opening.08:15-8:30 Welcome. Dr. Alfredo Rodríguez Antolín. AEU Vice-president. Dr. Fernando Mejía Estebaranz. Medical Director. 12 de Octubre University Hospital, Madrid, Spain. Dr. Juan Passas Martínez. Head of the Urology Service. 12 de Octubre University Hospital, Madrid, Spain.

SESSION I

PROSTATE CANCER: MANAGEMENT OF LOW AND INTERMEDIATE RISK.Chairs: Dr. Alfredo Rodríguez Antolín. Madrid / Prof. Joaquín Carballido Rodríguez. Madrid.

08:30-08:45 Active surveillance is the right management strategy for low-risk disease. Dr. Carlos Llorente. Madrid.

08:45-09:00 Utility of magnetic resonance imaging in active surveillance and focal therapy. Dr. Caroline Moore. London. 09:00-09:15 Focal therapy: indications and outcomes. Dr. Rafael Sánchez Salas. Paris.

09:15-09:30 Focal therapy: how to develop a new program. Dr. Juan Ignacio Martínez-Salamanca. Madrid.

09:30-10:00 Panel Discussion. Panelists: Dr. José Manuel Duarte Ojeda, Dr. Carlos Llorente, Prof. Joaquín Carballido Rodríguez, Dr. Caroline Moore, Dr. Rafael Sánchez Salas, Dr. Juan Ignacio Martínez-Salamanca.

10:00-10:30 Coffee break.

SESSION II

PROSTATE CANCER: HIGH-RISK AND ADVANCED PROSTATE CANCER. MANAGEMENT AND TREATMENT OUTCOMES.Chairs: Dr. Javier Romero-Otero. Madrid / Dr. Luis Martínez Piñeiro. Madrid.

1st

2 nd INTERNATIONAL MADRIDMEN´S HEALTH MEETING

Wednesday October 5th, 2016 10:30-10:45 Role of surgery in the management of high-risk and locally advanced prostate cancer. Dr. James Eastham. New York.

10:45-11:00 Adjuvant vs. early salvage radiation therapy. Dr. Alberto Bossi. Villejuif, France.

11:00-11:15 Management of node positive disease after radical prostatectomy. Prof. Xavier Cathelineau. Paris.

11:15-11:30 Role of radical prostatectomy in oligometastatic prostate cancer. Dr. Seva Matveev. Moscow.

11:30–11:45 Development of molecular imaging for diagnosis and treatment. Dr. Karim Touijer. New York.

11:45-12:15 Panel discussion. Chairs: Dr. Javier Romero-Otero. Madrid. / Dr. Luis Martínez Piñeiro. Madrid. Panelist: Dr. Seva Matveev, Dr. Karim Toujier, Dr. James Eastham, Prof. Xavier Cathelineau, Dr. Alberto Bossi.

SESSION IIIPROSTATE CANCER: SURGICAL TECHNIQUE.Chairs: Dr. José Manuel Duarte Ojeda. Madrid / Dr. James Eastham. New York / Dr. Alejandro Martín Parada. Salamanca.

12:15-12:30 Laparoscopic. Dr. Karim Touijer. New York.

12:30–12:45 Open RP. Dr. Alfredo Rodríguez Antolín. Madrid.

12:45–13:00 Robotic. Prof. Xavier Cathelineau. Paris.

13:00–13:15 Panel discussion. Chairs: Dr. José Manuel Duarte Ojeda. Madrid / Dr. James Eastham. New York / Dr. Alejandro Martín Parada. Salamanca.

Panelists: Dr. Karim Toujier, Dr. Alfredo Rodríguez Antolín, Prof. Xavier Cathelineau.

13:15-13:30 Prostate cancer hormone resistant: the landscape. Dr. Daniel Castellano Gauna. Madrid.

13:30-14:30 Lunch.

SESSION IVMANAGEMENT OF ERECTILE DYSFUNCTION WITH PENILE PROSTHESIS.Chairs: Dr. Natalio Cruz Navarro. Sevilla / Dr. Enrique Lledó García. Madrid / Dr. José Medina Polo. Madrid / Dr. Eduard Ruiz Castañé. Barcelona.

14:30-14:45 Double implant penile prosthesis and suburethral sling. Dr. Agustín Fraile Poblador. Madrid.

14:45-15:00 Penile prosthesis and fibrosis. Dr. Giulio Garaffa. London.

15:00-15:15 Does maleable prosthesis still have a role? Dr. Joaquim Sarquella Geli. Barcelona. 15:15-15:30 How to improve cosmetic and functional results during PP implant. Dr. Javier Romero-Otero. Madrid.

15:30-15:45 Complex penile prosthesis implants. Dr. Rados P. Djinovic. Belgrade.

15:45-16:00 Role of penile prosthesis in Peyronies disease. Dr. Borja García Gómez. Madrid.

16:00–16:15 Infrapubic penile prosthesis implantation. Dr. Josep Torremadé Barreda. Barcelona.

16:15-16:30 Penile and sphincter implantation. Dr. Juan Ignacio Martínez-Salamanca. Madrid.

16:30-17:00 Coffee Break.

SESSION V

BPH. Chairs: Dr. Alfredo Rodríguez Antolín. Madrid / Dr. Lucía García González. Madrid.

17:00-17:15 BPH Surgery: the History. Dr. Carlos Hernández Fernández. Madrid.

17:15-17:30 Green laser vaporization. Dr. Mario Domínguez Esteban. Santander.

17:30-17:45 Holmium enucleation. Dr. Javier Romero-Otero. Madrid.

17:45-18:00 Tulio enucleation. Dr. Giorgio Bozzini. Milan.

18:00 Closing Remarks and Adjournment.

DIRECTORS: Dr. Javier Romero-Otero / Dr. Karim Touijer / Dr. Alfredo Rodríguez Antolín

08:00 Opening.08:15-8:30 Welcome. Dr. Alfredo Rodríguez Antolín. AEU Vice-president. Dr. Fernando Mejía Estebaranz. Medical Director. 12 de Octubre University Hospital, Madrid, Spain. Dr. Juan Passas Martínez. Head of the Urology Service. 12 de Octubre University Hospital, Madrid, Spain.

SESSION I

PROSTATE CANCER: MANAGEMENT OF LOW AND INTERMEDIATE RISK.Chairs: Dr. Alfredo Rodríguez Antolín. Madrid / Prof. Joaquín Carballido Rodríguez. Madrid.

08:30-08:45 Active surveillance is the right management strategy for low-risk disease. Dr. Carlos Llorente. Madrid.

08:45-09:00 Utility of magnetic resonance imaging in active surveillance and focal therapy. Dr. Caroline Moore. London. 09:00-09:15 Focal therapy: indications and outcomes. Dr. Rafael Sánchez Salas. Paris.

09:15-09:30 Focal therapy: how to develop a new program. Dr. Juan Ignacio Martínez-Salamanca. Madrid.

09:30-10:00 Panel Discussion. Panelists: Dr. José Manuel Duarte Ojeda, Dr. Carlos Llorente, Prof. Joaquín Carballido Rodríguez, Dr. Caroline Moore, Dr. Rafael Sánchez Salas, Dr. Juan Ignacio Martínez-Salamanca.

10:00-10:30 Coffee break.

SESSION II

PROSTATE CANCER: HIGH-RISK AND ADVANCED PROSTATE CANCER. MANAGEMENT AND TREATMENT OUTCOMES.Chairs: Dr. Javier Romero-Otero. Madrid / Dr. Luis Martínez Piñeiro. Madrid.

1st

2 nd INTERNATIONAL MADRIDMEN´S HEALTH MEETING

Wednesday October 5th, 2016 10:30-10:45 Role of surgery in the management of high-risk and locally advanced prostate cancer. Dr. James Eastham. New York.

10:45-11:00 Adjuvant vs. early salvage radiation therapy. Dr. Alberto Bossi. Villejuif, France.

11:00-11:15 Management of node positive disease after radical prostatectomy. Prof. Xavier Cathelineau. Paris.

11:15-11:30 Role of radical prostatectomy in oligometastatic prostate cancer. Dr. Seva Matveev. Moscow.

11:30–11:45 Development of molecular imaging for diagnosis and treatment. Dr. Karim Touijer. New York.

11:45-12:15 Panel discussion. Chairs: Dr. Javier Romero-Otero. Madrid. / Dr. Luis Martínez Piñeiro. Madrid. Panelist: Dr. Seva Matveev, Dr. Karim Toujier, Dr. James Eastham, Prof. Xavier Cathelineau, Dr. Alberto Bossi.

SESSION IIIPROSTATE CANCER: SURGICAL TECHNIQUE.Chairs: Dr. José Manuel Duarte Ojeda. Madrid / Dr. James Eastham. New York / Dr. Alejandro Martín Parada. Salamanca.

12:15-12:30 Laparoscopic. Dr. Karim Touijer. New York.

12:30–12:45 Open RP. Dr. Alfredo Rodríguez Antolín. Madrid.

12:45–13:00 Robotic. Prof. Xavier Cathelineau. Paris.

13:00–13:15 Panel discussion. Chairs: Dr. José Manuel Duarte Ojeda. Madrid / Dr. James Eastham. New York / Dr. Alejandro Martín Parada. Salamanca.

Panelists: Dr. Karim Toujier, Dr. Alfredo Rodríguez Antolín, Prof. Xavier Cathelineau.

13:15-13:30 Prostate cancer hormone resistant: the landscape. Dr. Daniel Castellano Gauna. Madrid.

13:30-14:30 Lunch.

SESSION IVMANAGEMENT OF ERECTILE DYSFUNCTION WITH PENILE PROSTHESIS.Chairs: Dr. Natalio Cruz Navarro. Sevilla / Dr. Enrique Lledó García. Madrid / Dr. José Medina Polo. Madrid / Dr. Eduard Ruiz Castañé. Barcelona.

14:30-14:45 Double implant penile prosthesis and suburethral sling. Dr. Agustín Fraile Poblador. Madrid.

14:45-15:00 Penile prosthesis and fibrosis. Dr. Giulio Garaffa. London.

15:00-15:15 Does maleable prosthesis still have a role? Dr. Joaquim Sarquella Geli. Barcelona. 15:15-15:30 How to improve cosmetic and functional results during PP implant. Dr. Javier Romero-Otero. Madrid.

15:30-15:45 Complex penile prosthesis implants. Dr. Rados P. Djinovic. Belgrade.

15:45-16:00 Role of penile prosthesis in Peyronies disease. Dr. Borja García Gómez. Madrid.

16:00–16:15 Infrapubic penile prosthesis implantation. Dr. Josep Torremadé Barreda. Barcelona.

16:15-16:30 Penile and sphincter implantation. Dr. Juan Ignacio Martínez-Salamanca. Madrid.

16:30-17:00 Coffee Break.

SESSION V

BPH. Chairs: Dr. Alfredo Rodríguez Antolín. Madrid / Dr. Lucía García González. Madrid.

17:00-17:15 BPH Surgery: the History. Dr. Carlos Hernández Fernández. Madrid.

17:15-17:30 Green laser vaporization. Dr. Mario Domínguez Esteban. Santander.

17:30-17:45 Holmium enucleation. Dr. Javier Romero-Otero. Madrid.

17:45-18:00 Tulio enucleation. Dr. Giorgio Bozzini. Milan.

18:00 Closing Remarks and Adjournment.

DIRECTORS: Dr. Javier Romero-Otero / Dr. Karim Touijer / Dr. Alfredo Rodríguez Antolín

08:00 Opening.08:15-8:30 Welcome. Dr. Alfredo Rodríguez Antolín. AEU Vice-president. Dr. Fernando Mejía Estebaranz. Medical Director. 12 de Octubre University Hospital, Madrid, Spain. Dr. Juan Passas Martínez. Head of the Urology Service. 12 de Octubre University Hospital, Madrid, Spain.

SESSION I

PROSTATE CANCER: MANAGEMENT OF LOW AND INTERMEDIATE RISK.Chairs: Dr. Alfredo Rodríguez Antolín. Madrid / Prof. Joaquín Carballido Rodríguez. Madrid.

08:30-08:45 Active surveillance is the right management strategy for low-risk disease. Dr. Carlos Llorente. Madrid.

08:45-09:00 Utility of magnetic resonance imaging in active surveillance and focal therapy. Dr. Caroline Moore. London. 09:00-09:15 Focal therapy: indications and outcomes. Dr. Rafael Sánchez Salas. Paris.

09:15-09:30 Focal therapy: how to develop a new program. Dr. Juan Ignacio Martínez-Salamanca. Madrid.

09:30-10:00 Panel Discussion. Panelists: Dr. José Manuel Duarte Ojeda, Dr. Carlos Llorente, Prof. Joaquín Carballido Rodríguez, Dr. Caroline Moore, Dr. Rafael Sánchez Salas, Dr. Juan Ignacio Martínez-Salamanca.

10:00-10:30 Coffee break.

SESSION II

PROSTATE CANCER: HIGH-RISK AND ADVANCED PROSTATE CANCER. MANAGEMENT AND TREATMENT OUTCOMES.Chairs: Dr. Javier Romero-Otero. Madrid / Dr. Luis Martínez Piñeiro. Madrid.

1st

2 nd INTERNATIONAL MADRIDMEN´S HEALTH MEETING

Wednesday October 5th, 2016 10:30-10:45 Role of surgery in the management of high-risk and locally advanced prostate cancer. Dr. James Eastham. New York.

10:45-11:00 Adjuvant vs. early salvage radiation therapy. Dr. Alberto Bossi. Villejuif, France.

11:00-11:15 Management of node positive disease after radical prostatectomy. Prof. Xavier Cathelineau. Paris.

11:15-11:30 Role of radical prostatectomy in oligometastatic prostate cancer. Dr. Seva Matveev. Moscow.

11:30–11:45 Development of molecular imaging for diagnosis and treatment. Dr. Karim Touijer. New York.

11:45-12:15 Panel discussion. Chairs: Dr. Javier Romero-Otero. Madrid. / Dr. Luis Martínez Piñeiro. Madrid. Panelist: Dr. Seva Matveev, Dr. Karim Toujier, Dr. James Eastham, Prof. Xavier Cathelineau, Dr. Alberto Bossi.

SESSION IIIPROSTATE CANCER: SURGICAL TECHNIQUE.Chairs: Dr. José Manuel Duarte Ojeda. Madrid / Dr. James Eastham. New York / Dr. Alejandro Martín Parada. Salamanca.

12:15-12:30 Laparoscopic. Dr. Karim Touijer. New York.

12:30–12:45 Open RP. Dr. Alfredo Rodríguez Antolín. Madrid.

12:45–13:00 Robotic. Prof. Xavier Cathelineau. Paris.

13:00–13:15 Panel discussion. Chairs: Dr. José Manuel Duarte Ojeda. Madrid / Dr. James Eastham. New York / Dr. Alejandro Martín Parada. Salamanca.

Panelists: Dr. Karim Toujier, Dr. Alfredo Rodríguez Antolín, Prof. Xavier Cathelineau.

13:15-13:30 Prostate cancer hormone resistant: the landscape. Dr. Daniel Castellano Gauna. Madrid.

13:30-14:30 Lunch.

SESSION IVMANAGEMENT OF ERECTILE DYSFUNCTION WITH PENILE PROSTHESIS.Chairs: Dr. Natalio Cruz Navarro. Sevilla / Dr. Enrique Lledó García. Madrid / Dr. José Medina Polo. Madrid / Dr. Eduard Ruiz Castañé. Barcelona.

14:30-14:45 Double implant penile prosthesis and suburethral sling. Dr. Agustín Fraile Poblador. Madrid.

14:45-15:00 Penile prosthesis and fibrosis. Dr. Giulio Garaffa. London.

15:00-15:15 Does maleable prosthesis still have a role? Dr. Joaquim Sarquella Geli. Barcelona. 15:15-15:30 How to improve cosmetic and functional results during PP implant. Dr. Javier Romero-Otero. Madrid.

15:30-15:45 Complex penile prosthesis implants. Dr. Rados P. Djinovic. Belgrade.

15:45-16:00 Role of penile prosthesis in Peyronies disease. Dr. Borja García Gómez. Madrid.

16:00–16:15 Infrapubic penile prosthesis implantation. Dr. Josep Torremadé Barreda. Barcelona.

16:15-16:30 Penile and sphincter implantation. Dr. Juan Ignacio Martínez-Salamanca. Madrid.

16:30-17:00 Coffee Break.

SESSION V

BPH. Chairs: Dr. Alfredo Rodríguez Antolín. Madrid / Dr. Lucía García González. Madrid.

17:00-17:15 BPH Surgery: the History. Dr. Carlos Hernández Fernández. Madrid.

17:15-17:30 Green laser vaporization. Dr. Mario Domínguez Esteban. Santander.

17:30-17:45 Holmium enucleation. Dr. Javier Romero-Otero. Madrid.

17:45-18:00 Tulio enucleation. Dr. Giorgio Bozzini. Milan.

18:00 Closing Remarks and Adjournment.

1st

2nd INTERNATIONAL MADRID MEN´S HEALTH MEETING

Wednesday October 5th, 2016

12 de Octubre University Hospital.Madrid, Spain.

PROGRAMA DEFINITIVO

2 nd INTERNATIONAL MADRIDMEN´S HEALTH MEETING

www.madridmenshealthmeeting.com

1st

DATE: Wednesday October 5th, 2016

VENUE: 12 de Octubre University Hospital. Avda. de Córdoba s/n. 28041 - Madrid.

REGISTRATION FEE: €300 (+21% VAT)

The registration fee includes: Documentation, participation in scienti�c events, lunch and co�ees.

ORGANIZERS:

MAIN SPONSORS:

Operandro

SPD

-PTR

-5-1

6/IN

V

Gran Vía, 81 - 5º Dpto. 5 - 48011 Bilbao

Tel.: (0034) 94 427 88 55 | E-mail: info@congresosxxi.com

Simultaneous interpreting Spanish-English-Spanish will be available.

SUPPORTED BY:

Hospital Universitario12 de Octubre

TechnicalSecretariat:

COLLABORATORS:

Dr. Alberto Bossi. Gustave Roussy Cancer Institute in Villejuif, France.Dr. Giorgio Bozzini. Mater Domini Humanitas. Castellanza, Italy.Prof. Joaquín Carballido Rodríguez. Head Department of Urology, Puerta de Hierro-Majadahonda University Hospital. Madrid, Spain.

Dr. Daniel Castellano Gauna. 12 de Octubre University Hospital. Madrid, Spain.

Prof. Xavier Cathelineau. Institut Mutualiste Montsouris. Paris, France.

Dr. Natalio Cruz Navarro. ANDROMEDI Clinic. Andrology and Sexual Medicine. Sevilla, Spain.

Dr. Rados P. Djinovic. “Sava Perovic Foundation” Center for Genito-Urinary Reconstructive Surgery. Belgrade. ESGURS (EAU Section for Genito-Urinary Reconstructive Surgery)

Dr. Mario Domínguez Esteban. Marqués de Valdecilla University Hospital. Santander, Spain.

Dr. José Manuel Duarte Ojeda. Department of Urology, Prostatic Pathology Unit. 12 de Octubre University Hospital. Madrid, Spain.

Dr. James Eastham. Memorial Sloan Kettering Cancer Center. New York.

Dr. Agustín Fraile Poblador. Ramón y Cajal Universitary Hospital, Madrid.

Dr. Giulio Garaffa. St Peter's Andrology and the Institute of Urology, University College London Hospitals. London, England.

Dr. Borja García Gómez. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Lucía García González. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Carlos Hernández Fernández. Head Department of Urology, Gregorio

Marañón General University Hospital. Madrid, Spain.

Dr. Enrique Lledó García. Gregorio Marañón General University Hospital. Madrid, Spain.

Dr. Carlos Llorente. Hospital Universitario Fundación Alcorcón. Madrid, Spain.

Dr. Luis Martínez Piñeiro. Infanta Sofía University Hospital, Madrid, Spain.

Dr. Alejandro Martín Parada. Salamanca University Hospital. Salamanca, Spain.

Dr. Juan Ignacio Martínez-Salamanca. Puerta de Hierro-Majadahonda University Hospital. Madrid, Spain.

Dr. Seva Matveev. Head Department of Urology, N.N. Blokhin Cancer Research Center, Moscow. Professor of oncology, Lomonosov Moscow State University.

Dr. José Medina Polo. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Caroline Moore. University College London Hospital Trust. London, England.

Dr. Alfredo Rodríguez Antolín. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Javier Romero-Otero. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Eduard Ruiz Castañé. Puigvert Foundation, Barcelona, Spain.

Dr. Rafael Sánchez Salas. Institute Mutualiste Montsouris, Paris, France.

Dr. Joaquim Sarquella Geli. Puigvert Foundation, Barcelona, Spain.

Dr. Josep Torremadé Barreda. Bellvitge University Hospital, Barcelona, Spain.

Dr. Karim Touijer. Memorial Sloan Kettering Cancer Center. New York.

PARTICIPANTS

DIRECTORS:Dr. Javier Romero-Otero / Dr. Karim Touijer / Dr. Alfredo Rodríguez Antolín

1st

2nd INTERNATIONAL MADRID MEN´S HEALTH MEETING

Wednesday October 5th, 2016

12 de Octubre University Hospital.Madrid, Spain.

PROGRAMA DEFINITIVO

2 nd INTERNATIONAL MADRIDMEN´S HEALTH MEETING

www.madridmenshealthmeeting.com

1st

DATE: Wednesday October 5th, 2016

VENUE: 12 de Octubre University Hospital. Avda. de Córdoba s/n. 28041 - Madrid.

REGISTRATION FEE: €300 (+21% VAT)

The registration fee includes: Documentation, participation in scienti�c events, lunch and co�ees.

ORGANIZERS:

MAIN SPONSORS:

OperandroSP

D-P

TR-5

-16/

INV

Gran Vía, 81 - 5º Dpto. 5 - 48011 Bilbao

Tel.: (0034) 94 427 88 55 | E-mail: info@congresosxxi.com

Simultaneous interpreting Spanish-English-Spanish will be available.

SUPPORTED BY:

Hospital Universitario12 de Octubre

TechnicalSecretariat:

COLLABORATORS:

Dr. Alberto Bossi. Gustave Roussy Cancer Institute in Villejuif, France.Dr. Giorgio Bozzini. Mater Domini Humanitas. Castellanza, Italy.Prof. Joaquín Carballido Rodríguez. Head Department of Urology, Puerta de Hierro-Majadahonda University Hospital. Madrid, Spain.

Dr. Daniel Castellano Gauna. 12 de Octubre University Hospital. Madrid, Spain.

Prof. Xavier Cathelineau. Institut Mutualiste Montsouris. Paris, France.

Dr. Natalio Cruz Navarro. ANDROMEDI Clinic. Andrology and Sexual Medicine. Sevilla, Spain.

Dr. Rados P. Djinovic. “Sava Perovic Foundation” Center for Genito-Urinary Reconstructive Surgery. Belgrade. ESGURS (EAU Section for Genito-Urinary Reconstructive Surgery)

Dr. Mario Domínguez Esteban. Marqués de Valdecilla University Hospital. Santander, Spain.

Dr. José Manuel Duarte Ojeda. Department of Urology, Prostatic Pathology Unit. 12 de Octubre University Hospital. Madrid, Spain.

Dr. James Eastham. Memorial Sloan Kettering Cancer Center. New York.

Dr. Agustín Fraile Poblador. Ramón y Cajal Universitary Hospital, Madrid.

Dr. Giulio Garaffa. St Peter's Andrology and the Institute of Urology, University College London Hospitals. London, England.

Dr. Borja García Gómez. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Lucía García González. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Carlos Hernández Fernández. Head Department of Urology, Gregorio

Marañón General University Hospital. Madrid, Spain.

Dr. Enrique Lledó García. Gregorio Marañón General University Hospital. Madrid, Spain.

Dr. Carlos Llorente. Hospital Universitario Fundación Alcorcón. Madrid, Spain.

Dr. Luis Martínez Piñeiro. Infanta Sofía University Hospital, Madrid, Spain.

Dr. Alejandro Martín Parada. Salamanca University Hospital. Salamanca, Spain.

Dr. Juan Ignacio Martínez-Salamanca. Puerta de Hierro-Majadahonda University Hospital. Madrid, Spain.

Dr. Seva Matveev. Head Department of Urology, N.N. Blokhin Cancer Research Center, Moscow. Professor of oncology, Lomonosov Moscow State University.

Dr. José Medina Polo. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Caroline Moore. University College London Hospital Trust. London, England.

Dr. Alfredo Rodríguez Antolín. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Javier Romero-Otero. 12 de Octubre University Hospital. Madrid, Spain.

Dr. Eduard Ruiz Castañé. Puigvert Foundation, Barcelona, Spain.

Dr. Rafael Sánchez Salas. Institute Mutualiste Montsouris, Paris, France.

Dr. Joaquim Sarquella Geli. Puigvert Foundation, Barcelona, Spain.

Dr. Josep Torremadé Barreda. Bellvitge University Hospital, Barcelona, Spain.

Dr. Karim Touijer. Memorial Sloan Kettering Cancer Center. New York.

PARTICIPANTS

DIRECTORS:Dr. Javier Romero-Otero / Dr. Karim Touijer / Dr. Alfredo Rodríguez Antolín